Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Euro zone bonds hold ground, eyeing vaccinations, Fed

Tue, 16th Mar 2021 10:52

* Vaccine hurdles, Fed meeting support euro zone government
bonds

* France to raise 7 billion euros from new green bond

* Greece hires banks for first 30-year bond since 2008
(Adds details)

By Yoruk Bahceli

AMSTERDAM, March 16 (Reuters) - Euro zone government bonds
held ground on Tuesday, as caution set in before a U.S. Federal
Reserve meeting and uncertainty around vaccinations in the bloc
supported safe-haven assets.

Wednesday's Fed meeting is in focus amid expectations that
economic growth and inflation will rebound after U.S. fiscal
stimulus, which has pushed up government bond yields across the
world in recent weeks. The Fed has so been seen as downplaying
those concerns.

Safe-haven euro zone government bonds were also supported by
concerns around the bloc's vaccination efforts -- which already
lag the U.S. and Britain -- after Europe's largest economies
temporarily halted the use of AstraZeneca's
vaccine.

The vaccine currently encompasses around 25% of the vaccines
distributed across the European Union, and 15% of those so far
administered, according to Mizuho analysts.

Uncertainty around the AstraZeneca vaccine rollout "adds to
the general theme that the Eurozone is lagging behind in the
recovery from the pandemic", ING analysts told clients.

On Tuesday, Germany's 10-year yield, the benchmark for the
euro area, was down about a basis point at -0.34% at 1228 GMT,
far below the highest since March 2020 around -0.20% touched in
late February. Most other 10-year yields were unchanged to a
touch lower. Bond yields move inversely with prices.

The gap between 10-year German and U.S. Treasury yields --
an indicator that reflects the divergence between safe-haven
assets in the euro area and the United States -- remains just
shy of its highest since February 2020, as U.S. yields have
continued to rise this month while German Bund yields have
fallen.

Italian bonds underperformed, with the 10-year yield up 2
basis points to 0.63%, raising the closely watched risk premium
over German equivalents to 97 basis points.

Elsewhere, France will raise 7 billion euros from the sale
of its second green bond, which it is selling via a syndicate of
banks, according to memos from three lead managers seen by
Reuters showed.

And Greece hired a syndicate of banks for its first new
30-year bond sale since 2008. The deal will most likely launch
on Wednesday as the debt management office said it would come
"in the near future," a phrase usually used a day before a sale.

There was little reaction to Germany's ZEW economic research
institute survey, which showed investor sentiment in Europe's
leading economy increased more than expected in March.

A large majority of experts also expect inflation to
continue rising, and higher long-term interest rates, ZEW said.

(Reporting by Yoruk Bahceli, editing by Larry King and Ed
Osmond)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.